A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy

J. Kevin Hicks; Jeffrey R. Bishop; Roseann S. Gammal; Katrin Sangkuhl; Chad A. Bousman; J. Steven Leeder; Adrián Llerena; Daniel J. Mueller; Laura B. Ramsey; Stuart A. Scott; Todd C. Skaar; Kelly E. Caudle; Teri E. Klein; Andrea Gaedigk

doi:10.1002/cpt.1661

A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy

J. Kevin Hicks
, Jeffrey R. Bishop
, Roseann S. Gammal
, Katrin Sangkuhl
, Chad A. Bousman
, J. Steven Leeder
, Adrián Llerena
, Daniel J. Mueller
, Laura B. Ramsey
, Stuart A. Scott
, Todd C. Skaar
, Kelly E. Caudle
, Teri E. Klein
, Andrea Gaedigk

Research output: Contribution to journal › Comment/debate

25 Scopus citations

Original language	English
Pages (from-to)	50-52
Number of pages	3
Journal	Clinical Pharmacology and Therapeutics
Volume	107
Issue number	1
DOIs	https://doi.org/10.1002/cpt.1661
State	Published - 1 Jan 2020

Access to Document

10.1002/cpt.1661

Cite this

Hicks, J. K., Bishop, J. R., Gammal, R. S., Sangkuhl, K., Bousman, C. A., Leeder, J. S., Llerena, A., Mueller, D. J., Ramsey, L. B., Scott, S. A., Skaar, T. C., Caudle, K. E., Klein, T. E., & Gaedigk, A. (2020). A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy. Clinical Pharmacology and Therapeutics, 107(1), 50-52. https://doi.org/10.1002/cpt.1661

@article{2eecd4df17104b218fbb453c75a5d59d,

title = "A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy",

author = "Hicks, \{J. Kevin\} and Bishop, \{Jeffrey R.\} and Gammal, \{Roseann S.\} and Katrin Sangkuhl and Bousman, \{Chad A.\} and Leeder, \{J. Steven\} and Adri{\'a}n Llerena and Mueller, \{Daniel J.\} and Ramsey, \{Laura B.\} and Scott, \{Stuart A.\} and Skaar, \{Todd C.\} and Caudle, \{Kelly E.\} and Klein, \{Teri E.\} and Andrea Gaedigk",

note = "Funding Information: J.K.H. is funded by the H. Lee Moffitt Cancer Center \& Research Institute (NIH P30-CA076292), OneOme, and the American Society of Health Systems Pharmacists. R.S.G., K.E.C., K.S., and T.E.K. are funded by the National Institutes of Health (NIH) for CPIC (R24GM115264 and U24HG010135). K.S. and T.E.K. are funded by the NIH for PharmGKB (R24GM61374). J.S.L. is funded by grant U54 HD090258 for the Genomic- and Ontogeny-Linked Dose Individualization and Clinical Optimization for Kids from the Eunice Kennedy Shriver National Institute of Children Health and Human Development and the Sarli Family Foundation. L.B.R. is funded by grant R01HD089928 from the Eunice Kennedy Shriver National Institute of Children Health and Human Development. A.G. is funded by the NIH for PharmVar (R24 GM123930).",

year = "2020",

month = jan,

day = "1",

doi = "10.1002/cpt.1661",

language = "English",

volume = "107",

pages = "50--52",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "1",

}

Hicks, JK, Bishop, JR, Gammal, RS, Sangkuhl, K, Bousman, CA, Leeder, JS, Llerena, A, Mueller, DJ, Ramsey, LB, Scott, SA, Skaar, TC, Caudle, KE, Klein, TE & Gaedigk, A 2020, 'A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy', Clinical Pharmacology and Therapeutics, vol. 107, no. 1, pp. 50-52. https://doi.org/10.1002/cpt.1661

TY - JOUR

T1 - A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy

AU - Hicks, J. Kevin

AU - Bishop, Jeffrey R.

AU - Gammal, Roseann S.

AU - Sangkuhl, Katrin

AU - Bousman, Chad A.

AU - Leeder, J. Steven

AU - Llerena, Adrián

AU - Mueller, Daniel J.

AU - Ramsey, Laura B.

AU - Scott, Stuart A.

AU - Skaar, Todd C.

AU - Caudle, Kelly E.

AU - Klein, Teri E.

AU - Gaedigk, Andrea

N1 - Funding Information: J.K.H. is funded by the H. Lee Moffitt Cancer Center & Research Institute (NIH P30-CA076292), OneOme, and the American Society of Health Systems Pharmacists. R.S.G., K.E.C., K.S., and T.E.K. are funded by the National Institutes of Health (NIH) for CPIC (R24GM115264 and U24HG010135). K.S. and T.E.K. are funded by the NIH for PharmGKB (R24GM61374). J.S.L. is funded by grant U54 HD090258 for the Genomic- and Ontogeny-Linked Dose Individualization and Clinical Optimization for Kids from the Eunice Kennedy Shriver National Institute of Children Health and Human Development and the Sarli Family Foundation. L.B.R. is funded by grant R01HD089928 from the Eunice Kennedy Shriver National Institute of Children Health and Human Development. A.G. is funded by the NIH for PharmVar (R24 GM123930).

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://www.scopus.com/pages/publications/85074867473

U2 - 10.1002/cpt.1661

DO - 10.1002/cpt.1661

M3 - Comment/debate

C2 - 31664715

AN - SCOPUS:85074867473

SN - 0009-9236

VL - 107

SP - 50

EP - 52

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 1

ER -